Form 4: NeueHealth Director Acquires Warrants, Disclaims Beneficial Ownership
SEC Form 4
Paul Edward Walker, a director of NeueHealth, Inc., acquired warrants to purchase common stock but disclaims beneficial ownership due to his role in related investment partnerships.
Summary
- On October 1, 2024, Paul Edward Walker, a director of NeueHealth, Inc. (NEUE), acquired warrants to purchase common stock at an exercise price of $0.01.
- The warrants were issued pursuant to a Warrantholders Agreement dated April 8, 2024, and a Credit Agreement dated August 4, 2023, as amended.
- Walker disclaims beneficial ownership of the securities held by NEA 16, NEA 17, and NEA 18 VGE, as he is a manager of the general partners of these entities and has no direct pecuniary interest.
- The warrants expire on April 30, 2029.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing a transaction. The director disclaims beneficial ownership, which is a common practice in venture capital and private equity contexts.
Industry Context
This filing is a routine disclosure of insider transactions, providing transparency to the market regarding the holdings of company directors. It is common for directors to receive warrants as part of their compensation or as a result of company financing activities.
Stakeholder Impact
- The acquisition of warrants by a director could be perceived positively by shareholders as it aligns the director's interests with the company's success.
- However, the disclaimer of beneficial ownership might raise questions about the director's direct stake in the company's performance.
Key Dates
| Date | Description |
|---|---|
| August 4, 2023 | Date of the Credit Agreement between the Issuer and the lenders thereto. |
| October 2, 2023 | Date of Incremental Amendment No. 1 to the Credit Agreement. |
| April 8, 2024 | Date of the Warrantholders Agreement and Incremental Amendment No. 2 to the Credit Agreement. |
| October 1, 2024 | Date of the warrant acquisition transaction. |
| October 2, 2024 | Deemed execution date for warrant acquisition. |
| October 3, 2024 | Date of the Form 4 filing. |
| April 30, 2029 | Expiration date of the warrants. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.